Michiels M J, Bergeron M G
Centre de Recherche en Infectiologie, Centre Hospitalier de l'Université Laval, Québec, Canada.
Antimicrob Agents Chemother. 1996 Jan;40(1):203-11. doi: 10.1128/AAC.40.1.203.
A possible explanation for the difficulties encountered in curing deep fibrin-embedded infections is that antibiotic diffusion inside the infected fibrin matrix is not homogeneous and is insufficient to neutralize the pathogen. To evaluate this conjecture, the differential pharmacodynamics of daptomycin in fibrin clots infected with methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis was estimated. Daptomycin (20 or 50 mg/kg of body weight) was infused over 30 min. Fibrin clots and blood samples were evaluated from 0.5 to 42 h after the injections. The half-lives of daptomycin in serum and fibrin clot were close to identical after the two doses and averaged 5.4 and 22 h, respectively. The mean areas under the concentration-time curves from 0 to 42 h (AUC0-infinity) for daptomycin concentrations in serum and infected clots were 575 +/- 36.7 and 215 +/- 6.2 micrograms/g/h after administration of 20 mg/kg and 1,089 +/- 39.9 and 326 +/- 16.8 micrograms/g/h after administration of 50 mg/kg. A concentration gradient from the periphery to the core of the clots was observed in many clots up to 18 h after treatment. Mean peak concentrations in the core of the clots reached 60% of the peripheral values (P < 0.05) and were delayed for at least 3 h compared with the peripheral peak concentrations. AUC0-42 h of daptomycin concentration in the periphery and the core of clots were significantly different (P < 0.01). Survival of microorganisms was better in the core than in the periphery, with as much as a 3 log10 CFU/g difference between the center and the surface of the clot. Bacterial examination by transmission electron microscopy also showed noticeable differences in ultrastructural changes between those in the periphery and those in the core of the clots. In conclusion, the pharmacokinetics of daptomycin are significantly different at the periphery and within the core of fibrin clots, which may have led to the higher bacterial survival in the core of clots. Limited diffusion of daptomycin in fibrin, an essential component of the vegetation in bacterial endocarditis, could explain at least in part some of the treatment failures.
治愈深层纤维蛋白包埋感染时遇到困难的一个可能解释是,抗生素在受感染的纤维蛋白基质内的扩散不均匀,不足以中和病原体。为评估这一推测,对达托霉素在感染了甲氧西林敏感和耐药金黄色葡萄球菌以及表皮葡萄球菌的纤维蛋白凝块中的差异药效学进行了评估。以30分钟的时间输注达托霉素(20或50mg/kg体重)。在注射后0.5至42小时对纤维蛋白凝块和血液样本进行评估。两剂给药后,达托霉素在血清和纤维蛋白凝块中的半衰期接近相同,分别平均为5.4小时和22小时。给药20mg/kg后,血清和感染凝块中达托霉素浓度的0至42小时浓度-时间曲线下面积(AUC0-∞)平均值分别为575±36.7和215±6.2μg/g/h,给药50mg/kg后分别为1,089±39.9和326±16.8μg/g/h。在许多凝块中,直至治疗后18小时,均观察到从凝块周边到核心的浓度梯度。凝块核心的平均峰值浓度达到周边值的60%(P<0.05),并且与周边峰值浓度相比延迟至少3小时。凝块周边和核心中达托霉素浓度的AUC0-42小时存在显著差异(P<0.01)。微生物在核心中的存活情况比在周边更好,凝块中心和表面之间的差异高达3 log10 CFU/g。通过透射电子显微镜进行的细菌检查也显示,凝块周边和核心的超微结构变化存在明显差异。总之,达托霉素在纤维蛋白凝块周边和核心的药代动力学存在显著差异,这可能导致凝块核心中细菌存活率较高。达托霉素在纤维蛋白(细菌性心内膜炎赘生物的重要组成部分)中的扩散受限,至少可以部分解释一些治疗失败的原因。